☀ New York | Saturday November 7, 2026 | Sign In
⚡ TRENDING NOW

Breakthrough in Drug Design: Tiny Rings Simplify Medicine Creation

Laboratory molecular ring synthesis setup.
Laboratory molecular ring synthesis setup.

Researchers have developed a new method to produce aminocyclopropanes, tiny molecular rings with potential to improve drug design. These structures, formed by connecting carbon triangles to an amine, can replace common substructures in medicines, altering their properties. Cyclopropanes, the smallest rings in organic chemistry, consist of three carbon atoms in a triangle, creating a strained yet versatile structure. This unique geometry is found in many biologically active compounds, from antidepressants to antibiotics, making them valuable in drug discovery.

The team, led by Nuno Maulide at the University of Vienna, created a process called hydroaminoalkylation. It uses a stable starting material, hemiaminal, which reacts at room temperature without needing air- or water-free conditions. This approach contrasts sharply with traditional methods, which often require highly reactive chemicals, metal reagents, and strict environmental controls. By simplifying the process, the researchers have made aminocyclopropane synthesis more accessible and practical for medicinal chemists.

A gentler approach to complex molecules

Traditional methods for making aminocyclopropanes often require harsh chemicals, metal reagents, and multiple steps. These conditions limit the types of molecules that can be modified, a challenge in medicinal chemistry. The new method overcomes these limitations by tolerating functional groups like alcohol, carbonyl, and phthalimide, which are typically problematic in established approaches. This flexibility is key for modifying complex molecules without disrupting their structure, a common need in drug development.

They also applied it to a complex molecule derived from the hormone estrone. Notably, the reaction was scaled to over 1 gram in a single run while maintaining an impressive 84% yield, demonstrating its efficiency and scalability for larger-scale applications.

Related Post: AI tool speeds drug discovery with massive cloud screening

One-pot simplicity and broader applications

The researchers further simplified the process by developing a one-pot, three-component reaction. This eliminates the need to prepare the hemiaminal separately, using only commercially available materials. By streamlining the synthesis, this approach reduces costs and time, making it more feasible for high-throughput drug discovery efforts. The method’s compatibility with alkynes further expands its utility, enabling the creation of a wider range of molecular structures.

Proof of concept: modifying a stimulant

As a test, the team used their method to create a molecule similar to phentermine, a stimulant. By replacing a specific structural feature with an aminocyclopropane, they retained its activity at certain neurotransmitter transporters while reducing dopamine release, potentially lowering the risk of dependence. This modification highlights the precision of the method in fine-tuning molecular properties, a key advantage in drug design.

This demonstrates how aminocyclopropanes can subtly alter a molecule’s behavior while preserving desired effects. Bioisosteres, like aminocyclopropanes, are valuable tools for medicinal chemists, allowing them to fine-tune drug properties. By replacing α,α-gem-dimethylamines with aminocyclopropanes, researchers can systematically modify molecules to optimize their biological activity and metabolic stability, addressing challenges in drug development.

Nuno Maulide, corresponding author of the study, said, “Not only could we show that such molecular triangles can be made quickly and easily using mild conditions, our work demonstrates how replacing one structural element with an aminocyclopropane can substantially alter a molecule’s biological behaviour without eliminating its desired activity. This makes the current study a very important milestone in this field.” Konstantin Günther, co-first author, emphasized the importance of balancing molecular properties in drug discovery, while Gwyndaf Oliver, another co-first author, highlighted the role of bioisosteres in making precise structural changes. Their work provides both a practical synthesis method and a compelling case for using aminocyclopropanes in pharmaceutical research, ultimately contributing to the advancement of drug discovery and development.

Leave a Reply

Your email address will not be published. Required fields are marked *